# Millendo Therapeutics, Inc.: Form D filings

Millendo Therapeutics, Inc., a pharmaceuticals company in Ann Arbor, MI, filed 6 Form D notices with the SEC between 2012 and 2017. The latest, on December 28, 2017, reports $50 million sold of a $59.1 million offering to 14 investors.

Find out what Millendo Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Millendo%20Therapeutics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Millendo%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmillendo-therapeutics-inc-1547547)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Millendo%20Therapeutics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Millendo%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmillendo-therapeutics-inc-1547547)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Michigan](https://specstream.ai/data/form-d/state/michigan): 506 rows, by operating companies, filed since November 1, 2024, $25.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/michigan
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 301 NORTH MAIN STREET, SUITE 100, Ann Arbor, MI, 48104
- Phone: (734) 845-9000
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1547547

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 28, 2017 | New notice | $59,109,960 | $50,043,201 | $9,066,759 | 14 | Dec 19, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547547/000154754717000001/0001547547-17-000001-index.htm) |
| Jan 4, 2016 | New notice | $70,702,987 | $47,697,172 | $23,005,815 | 21 | Dec 18, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547547/000154754716000002/0001547547-16-000002-index.htm) |
| Feb 26, 2013 | Amendment | $16,633,013 | $8,522,872 | $8,110,141 | 7 | Jul 25, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547547/000154754713000002/0001547547-13-000002-index.htm) |
| Sep 27, 2012 | Amendment | $16,633,013 | $3,506,411 | $13,126,602 | 6 | Jul 25, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547547/000154754712000005/0001547547-12-000005-index.htm) |
| Aug 3, 2012 | New notice | $16,633,013 | $1,506,411 | $15,126,602 | 4 | Jul 25, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547547/000154754712000003/0001547547-12-000003-index.htm) |
| Apr 23, 2012 | New notice | $500,000 | $250,000 | $250,000 | 1 | Apr 17, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547547/000154754712000001/0001547547-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Pharis Mohideen | Executive Officer |  |
| James Hindman | Director |  |
| Christopher Seiter | Executive Officer |  |
| Thierry Abribat | Director |  |
| James Topper | Director |  |
| Randall Whitcomb | Director |  |
| Julia Owens | Executive Officer, Director |  |
| Carol Gallagher | Director |  |
| Carole Neuchterlein | Director |  |
| Jeffery Brinza | Executive Officer |  |
| Mary Lynne Hedley | Director |  |

## Other pharmaceuticals companies in Michigan that filed recently

- [IMACS Working Capital Facility One LLC](https://specstream.ai/data/form-d/company/imacs-working-capital-facility-one-llc-2155969) $200,000 · Sep 17, 2026

[Every Form D from the week of Dec 25, 2017](https://specstream.ai/data/form-d/week/2017-12-25) · [All recent filings in Michigan](https://specstream.ai/data/form-d/state/michigan) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Millendo Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).